Glaucoma Surgery Devices are used to augment normal physiologic aqueous outflow pathways in order to provide effective intra-ocular pressure. Glaucoma drainage devices are designed to divert aqueous humor from the anterior chamber to an external reservoir, where a fibrous capsule forms about 4-6 weeks after surgery and regulates flow.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Glaucoma Surgery Devices under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Glaucoma Surgery Devices and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy
The report enables you to:
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Glaucoma Surgery Devices under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Alievio Inc
- Allergan Ltd
- Assenti, LLC
- Avisi Technologies LLC
- Chongqing Migos Medical Technology Co Ltd
- Ciliatech Therapeutics AG
- Corneat Vision Ltd
- Eye Sonix
- Galaxy Ophthalmics Inc (Inactive)
- Geuder AG
- Glaucot Teknoloji AS
- Glaukos Corp
- Health Guard Biomed (Suzhou) Biomedical Technology Co Ltd
- HiSilicon (Suzhou) Biomedical Technology Co Ltd
- Iantrek Inc
- InnFocus Inc
- iScience Interventional Inc
- iSTAR Medical SA
- iVeena Delivery Systems Inc
- Johns Hopkins University
- Kytogenics Pharmaceuticals Inc
- Liqid Medical (Pty) Ltd
- Medtronic Plc
- Meir Medical Center
- Merz Anteis SA
- MicroOptx Inc
- Mingche Biotechnology (Suzhou) Co Ltd
- Myra Vision Inc
- Ocumatrx
- OcuTherix Inc
- OPKO Health Inc
- OptoLight Vision Technology
- Purdue University
- Queen's University
- Rheon Medical SA
- Sight Sciences Inc
- Stanford University
- Suzhou Langmu Medical Technology Co Ltd
- Tel Aviv University
- The Chaim Sheba Medical Center
- The University of Texas at Austin Division of Housing and Food Service
- University of Colorado
- University of Colorado Anschutz Medical Campus
- University of Florida
- University of Michigan
- University of Oslo
- Vivid White Pty Ltd
- Westhouse Medical Services Plc (Inactive)